retatrutide clinical trial near me Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 trials, is being sold openly across the internet and prescribed by licensed physicians online and A Study of Retatrutide (LY3437943)

This dramatic shift is not random

Clinical trials and regulatory approvals for GLP-1 drugs like Semaglutide have largely focused on adult patients, driving widespread adoption in this age group

Dana Cohen's GLP-1 treatment offers a tailored approach to weight management that addresses the root causes of metabolic challenges while providing sustainable, long-lasting results

Constipation may occur in up to 35% of patients treated for obesity, which often requires higher doses of GLP-1 therapy

No washout period is required

Although comparison studies with GLP-1 RA's have been conducted in the past, new doses have since been approved, making it difficult to compare tirzepatide to GLP-1 RA's based on previous studies